Workflow
非经常性损益
icon
Search documents
鑫宏业: 北京德皓国际会计师事务所(特殊普通合伙)关于无锡鑫宏业线缆科技股份有限公司三年一期非经常性损益鉴证报告
Zheng Quan Zhi Xing· 2025-09-05 11:22
| 非经常性损益鉴证报告 | | | | | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 德皓核字[2025]00001516 | | | | | | | | | | | | | 号 | | | | | 京 皓 所 | 北 | 德 | 国 | 际 | 会 | 计 | 师 | 事 | 务 | (特 | 殊 | 普 | 通 合 伙 | | ) | | | Beijing Dehao International Public | | | | | | | | Certified | | | | Accountants | (Limited | | | Liability | | Partnership) | | | | | | | | | | | | | | | | | | 无锡鑫宏业线缆科技股份有限公司 | | | | | | | | | | | | | | | | | | 非经常性损益鉴证报告 | | ...
智明达: 成都智明达电子股份有限公司2025年1-6月、2024年度、2023年度及2022年度非经常性损益明细表及鉴证报告
Zheng Quan Zhi Xing· 2025-09-02 11:25
成都智明达电子股份有限公司 及 2022 年 度 非经常性损益明细表及鉴证报告 索引 页码 非经常性损益的鉴证报告 1-2 我们审核了后附的成都智明达电子股份有限公司(以下简称智明达公司)2022年 度、2023年度、2024年度及2025年1-6月的非经常性损益明细表。 一、管理层的责任 智明达公司管理层的责任是按照中国证券监督管理委员会颁布的《公开发行证券 的公司信息披露解释性公告第1号--非经常性损益(2023年修订)》(证监会公告 [2023]65号)的规定编制非经常性损益明细表,并保证其内容真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏。 二、注册会计师的责任 非经常性损益明细表 1-2 非经常性损益的鉴证报告 XYZH/2025BJAG1B0423 成都智明达电子股份有限公司 成都智明达电子股份有限公司全体股东: 我们的责任是在执行鉴证工作的基础上,对智明达公司管理层编制的上述明细表 发表鉴证意见。我们按照中国注册会计师执业准则的规定执行了鉴证业务。中国注册 会计师执业准则要求我们遵守中国注册会计师职业道德守则,计划和执行鉴证工作以 对明细表是否不存在重大错报获取合理保证。在鉴证过程中, ...
主业承压、非经常性损益“救场”,旅游及景区上市公司上半年业绩分化加剧
Sou Hu Cai Jing· 2025-08-30 08:39
Core Insights - The tourism and scenic area industry has shown a mixed performance in the first half of 2025, with 23 listed companies reporting a total revenue of 17.55 billion yuan, a year-on-year increase of 4.8%, but a net profit of 1.167 billion yuan, down 4.25% [2][3] - The divergence in performance among companies is attributed to differences in tourism resources, location conditions, operational models, and capital operation capabilities, reflecting a deepening marketization process in the tourism industry [2][3] Revenue Performance - Among the listed companies, China Youth Travel Service (中青旅) led with a revenue of 4.866 billion yuan, while Tibet Tourism (西藏旅游) reported less than 100 million yuan [3][4] - Ten companies achieved positive revenue growth, with Tianfu Culture and Tourism (天府文旅) leading at an 86.75% increase, followed by Xiangyuan Culture and Tourism (祥源文旅) at 35.41% and Jiuhua Tourism (九华旅游) at 22.26% [3][4] Profitability Analysis - Seven companies, including Changbai Mountain (长白山) and Dalian Shengya (大连圣亚), reported losses, with Changbai Mountain transitioning from profit to loss due to extreme weather and rising costs [4][8] - Companies like Guilin Tourism (桂林旅游) and Tibet Tourism achieved profitability through non-recurring gains, with Guilin reporting a net profit of 8 million yuan, a 141.94% increase [4][5] Challenges Faced - Extreme weather and cost pressures were significant factors leading to losses for several companies, with Changbai Mountain and Dalian Shengya both citing decreased visitor numbers and increased operational costs [8][9] - Yunnan Tourism experienced a substantial revenue decline of 61.22%, primarily due to project delays and losses from its subsidiaries [10] Notable Performers - Xiangyuan Culture and Tourism was the only company to achieve over 30% growth in both revenue and net profit, with a revenue of 500 million yuan and a net profit of 92 million yuan [11] - ST Zhangjiajie (ST张家界) reported a revenue increase of 11.40% to 194 million yuan, with a significant reduction in net loss by 45.60% [12] Visitor Trends - Visitor numbers showed significant variation, with Jiuhua Mountain receiving approximately 5.65 million visitors, a year-on-year increase of 11.81%, while Emei Mountain and Lijiang saw declines in visitor numbers [13]
中科星图: 中科星图股份有限公司2022年度、2023年度、2024年度及2025年1-6月非经常性损益明细表及鉴证报告
Zheng Quan Zhi Xing· 2025-08-29 17:25
Core Viewpoint - The report provides a reasonable assurance conclusion regarding the non-recurring profit and loss statement of Zhongke Xingtou Co., Ltd. for the years 2022, 2023, 2024, and the first half of 2025, confirming that it has been prepared in accordance with the relevant regulations set by the China Securities Regulatory Commission [1][3]. Group 1: Management and Auditor Responsibilities - The management of Zhongke Xingtou is responsible for preparing the non-recurring profit and loss statement in accordance with the guidelines issued by the China Securities Regulatory Commission, ensuring its truthfulness, accuracy, and completeness [1][2]. - The auditor's responsibility is to provide a reasonable assurance conclusion based on the verification work performed on the non-recurring profit and loss statement [2]. Group 2: Verification Process - The verification was conducted following the standards for other assurance services, requiring adherence to professional ethics and the implementation of necessary procedures such as verification, inquiry, and sampling of accounting records [2]. Group 3: Conclusion and Usage - The conclusion states that the non-recurring profit and loss statement accurately reflects the financial situation of Zhongke Xingtou for the specified periods, in all material respects [3]. - The report is intended solely for the purpose of refinancing by Zhongke Xingtou and should not be used for any other purposes [3].
华润入主首考:天士力靠1.35亿“输血”扮靓净利,核心业务承压
Xin Lang Zheng Quan· 2025-08-27 09:32
Core Insights - The company reported a revenue of 4.288 billion yuan for the first half of 2025, a year-on-year decline of 1.91% [1] - The pharmaceutical manufacturing and commercial sectors both experienced significant downturns, with manufacturing revenue slightly decreasing by 0.45% to 3.879 billion yuan and commercial revenue plummeting by 14.88% [1] - Despite the revenue decline, the net profit attributable to shareholders increased by 16.97% to 775 million yuan, largely due to non-recurring gains of 135 million yuan [1][2] - The core product, Dan Shen Drop Pill, saw a revenue decline of 2.98% in the cardiovascular and metabolic sector, contributing to the overall performance issues [1] Financial Performance - Non-recurring gains of 135 million yuan were primarily from non-current asset disposals, government subsidies, and changes in the fair value of financial assets, masking the weakness in core business operations [2] - The gross margin for the pharmaceutical manufacturing sector decreased by 0.7 percentage points, leading to an overall gross margin drop to 67.54%, indicating challenges in cost control and product competitiveness [2] - Operating cash flow net amount fell by 10.95% to 790 million yuan, while accounts receivable surged by 46.86% to 1.169 billion yuan, increasing the proportion of receivables to 27.26% of revenue, highlighting rising collection pressures and potential bad debt risks [2] Management Changes and Strategic Outlook - Following the change in control, the management team underwent significant restructuring, with the founder's son stepping down as chairman and nearly ten core executives leaving the company [3] - The integration process under the new ownership by China Resources is still in its early stages, raising questions about the company's ability to revitalize amidst industry challenges and stagnant core product growth [3] - The reliance on non-recurring gains for profit growth raises concerns about sustainability, as deep-rooted issues such as high accounts receivable, weakened cash flow, and sluggish core business growth have emerged [3]
联瑞新材: 华兴会计师事务所(特殊普通合伙)关于江苏联瑞新材料股份有限公司最近三年及一期非经常性损益鉴证报告
Zheng Quan Zhi Xing· 2025-08-26 16:35
Group 1 - The report is a verification report on the non-recurring gains and losses of Jiangsu Lianrui New Materials Co., Ltd. for the years 2022, 2023, 2024, and the first half of 2025 [1] - The report is intended solely for the purpose of issuing convertible bonds to unspecified parties and cannot be used for other purposes [1] - The management of Lianrui New Materials is responsible for providing accurate and complete information in accordance with the relevant regulations set by the China Securities Regulatory Commission [1] Group 2 - The responsibility of the registered accountant is to provide a verification conclusion based on the verification work conducted on the non-recurring gains and losses detailed by the management [2]
亚星锚链: 亚星锚链2025年半年度报告
Zheng Quan Zhi Xing· 2025-08-25 16:42
Core Viewpoint - Jiangsu Asian Star Anchor Chain Co., Ltd. reported a net profit attributable to shareholders of 114,550,828.73 yuan for the first half of 2025, a decrease of 17.43% compared to the same period last year, with total revenue reaching 991,420,125.05 yuan, up 5.88% year-on-year [1][2]. Financial Performance - The company achieved a total revenue of 991,420,125.05 yuan, compared to 936,385,343.09 yuan in the same period last year, reflecting a growth of 5.88% [2][4]. - The total profit for the period was 132,629,111.15 yuan, down 19.90% from 165,577,967.42 yuan year-on-year [2][4]. - The net profit attributable to shareholders decreased to 114,550,828.73 yuan from 138,732,920.58 yuan, marking a decline of 17.43% [2][4]. - The basic earnings per share were 0.1194 yuan, down from 0.1446 yuan, a decrease of 17.43% [2][4]. Operational Highlights - The company sold a total of 84,348 tons of products, an increase of 7.74% year-on-year, with significant growth in sales of mooring chains, which rose by 55.31% to 19,524 tons [3][4]. - The company secured orders totaling 14.27 million tons, maintaining a leading position with 56.2% of the global order volume [3][4]. Industry Context - The company operates in the specialized anchor chain manufacturing sector, producing essential components for maritime and offshore engineering, which are critical for the safety of vessels and marine facilities [3][4]. - The international offshore oil and gas engineering industry is experiencing steady growth, with deepwater oil and gas becoming a core area for global reserves and production [3][4]. Investment and Financial Position - The company reported total assets of 5,331,566,214.92 yuan, an increase of 0.75% from the previous year [2][4]. - The net assets attributable to shareholders were 3,644,502,529.15 yuan, reflecting a slight increase of 0.51% [2][4]. - Cash flow from operating activities was reported at 50,536,758.35 yuan, a significant recovery from a negative cash flow of -133,786,969.20 yuan in the previous year [2][4].
山东墨龙(00568) - 海外监管公告
2025-08-22 10:41
香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 的 內 容 概 不 負 責 , 對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明 , 並 表 明 不 會 就 本 公 告 全 部 或 任 何 部 分 內 容 或 因 依 賴 該 等 內 容 而 引 致 的 任 何 損 失 承 擔 任 何 責 任 。 * ( 於 中 華 人 民 共 和 國 註 冊 成 立 的 中 外 合 資 股 份 有 限 公 司 ) ( 股 份 代 號 : 5 6 8) 海外監管公告 本 公 告 乃 根 據 香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則 第 13. 10B 條 而 作 出 。 茲 載 列 山 東 墨 龍 石 油 機 械 股 份 有 限 公 司 ( 「 本 公 司 」 ) 在 中 國 報 章 刊 登 或 在 深 圳 證 券 交 易 所 網 站 發 佈 的 日 期 為 二 零 二 五 年 八 月 二 十 三 日 的 《 2025 年 半 年 度 報 告 摘 要 》《 2025 年 半 年 度 報 告 》《 2025 年 半 年 度 ...
法尔胜: 非经常性损益审核报告(中兴华核字(2025)第020104号)
Zheng Quan Zhi Xing· 2025-08-14 11:18
最近三年及一期非经常性损益的专项审核报告 江苏法尔胜股份股份有限公司 非经常性损益审核报告书 中兴华会计师事务所(特殊普通合伙) ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地址:北京市丰台区丽泽路 20 号丽泽 SOHO B座 20 层 邮编:100073 电话:(010) 51423818 传真:(010) 51423816 目 录 一、审核报告 二、审核报告附送 中兴华会计师事务所(特殊普通合伙) Z H O N G X I N G H U A C E RT I F I E D P U B L I C A C C O U N TA N T S L L P 地 址 ( l o c a t i o n ): 北 京 市 丰 台 区 丽 泽 路 2 0 号 丽 泽 S O H O B 座 20 层 电 话 ( t e l ): 0 1 0 - 5 1 4 2 3 8 1 8 传 真 ( f a x ): 0 1 0 - 5 1 4 2 3 8 1 6 关于江苏法尔胜股份有限公司 中兴华核字(2025)第 020104 号 江苏法尔胜股份有限公司全体股东: 我们接 ...
3架飞机被扣俄罗斯!最新公告:已收到1.6亿元保险赔款
Sou Hu Cai Jing· 2025-08-12 04:45
Summary of Key Points Core Viewpoint - The company Shanhai Intelligent has received insurance compensation for three aircraft that were stranded in Russia due to geopolitical conflicts since February 2022, which affected the aviation industry and led to sanctions [1][4]. Group 1: Aircraft Leasing and Insurance Compensation - Shanhai Intelligent's wholly-owned subsidiary AVMAX had signed three aircraft leasing contracts with Russian clients, which became problematic due to the geopolitical situation [1]. - AVMAX attempted multiple times to recall the leased aircraft from Russia but was unsuccessful [1]. - AVMAX reached an agreement with the insurance underwriter, confirming an insurance claim amount of $29 million, with a net amount of $22.9651 million after deducting legal fees [4]. Group 2: Financial Impact - The total insurance compensation received by AVMAX amounts to approximately 164 million RMB, based on the exchange rate as of August 8 [4]. - After tax deductions, the impact on the company's net profit from the insurance compensation is estimated to be 126 million RMB, which represents 172.92% of the company's net profit attributable to shareholders from the previous year [4]. - The compensation is classified as a non-recurring gain, as AVMAX had previously fully provided for impairment on the three aircraft [4].